Skip to main content
. Author manuscript; available in PMC: 2014 Jan 1.
Published in final edited form as: Neurodegener Dis. 2012 Jul 10;11(4):165–181. doi: 10.1159/000337230

Figure 2. Detection of Aβ42 in the brain after acute intra-cerebral injection of oligomers.

Figure 2

100μM Aβ42-derived oligomers (OLIGO) were injected in the cortex and hippocampus of nontransgenic (ntg) mice for 1 hr (A, arrows indicating the injection sites, n=3). 100μM OLIGO was injected in brain regions of rTg4510 mice for 3 days (B n=5). Tissue was stained for Aβ immunoreactivity. The scale bar is 1000μm for both panels.